Paper8538712
Acellular pertussis vaccines for infants.
Edwards KM and 1 other. N Engl J Med, 1996. Cited by 62 papers, by iCite.
Cite this record
ConductScience Library. Acellular pertussis vaccines for infants. Papers, record 8538712. Release papers-2026-11-12-0.1.0, 12 Nov 2026. https://conductscience.org/library/papers/8538712
- Sources
- 11 sources
- Release
- papers-2026-11-12-0.1.0
Paper
PubMed's record of the paper, with iCite's citation figures. No abstract is shown.
Topics11
NLM's MeSH indexing of the paper, its major topics first.
| MeSH term | Major |
|---|---|
| Pertussis Vaccine | Major topic |
| Whooping Cough | Major topic |
| Antigens, Bacterial | |
| Bordetella pertussis | |
| Diphtheria Toxoid | |
| Diphtheria-Tetanus Vaccine | |
| Humans | |
| Infant | |
| Tetanus Toxoid | |
| Treatment Outcome | |
| Vaccines, Combined |
Source PubMed
Comments and corrections4
PubMed's comments and corrections, NLM's own indexing: retractions first, then expressions of concern, errata and updates, and comments last.
| Kind | PMID | Title | In Papers | Source |
|---|---|---|---|---|
| Comment in | 8618620 | Acellular pertussis vaccines. | https://conductscience.org/library/papers/8618620 | PubMed |
| Comment in | 8618621 | Acellular pertussis vaccines. | https://conductscience.org/library/papers/8618621 | PubMed |
| Comment on | 8538704 | A controlled trial of two acellular vaccines and one whole-cell vaccine against pertussis. Progetto Pertosse Working Group. | https://conductscience.org/library/papers/8538704 | PubMed |
| Comment on | 8538705 | A controlled trial of a two-component acellular, a five-component acellular, and a whole-cell pertussis vaccine. | https://conductscience.org/library/papers/8538705 | PubMed |
Cited by17
The papers in our copy of PubMed whose reference list names this one, newest first. iCite, which reads more sources, counts 62 citations.
| PMID | Title | Journal | Year | In Papers | Source |
|---|---|---|---|---|---|
| 39684849 | Current Progress in the Development of mRNA Vaccines Against Bacterial Infections. | Int J Mol Sci | 2024 | https://conductscience.org/library/papers/39684849 | PubMed |
| 39205626 | The contributions of T cell-mediated immunity to protection from vaccine-preventable diseases: A primer. | Hum Vaccin Immunother | 2024 | https://conductscience.org/library/papers/39205626 | PubMed |
| 31333640 | Pertussis Prevention: Reasons for Resurgence, and Differences in the Current Acellular Pertussis Vaccines. | Front Immunol | 2019 | https://conductscience.org/library/papers/31333640 | PubMed |
| 30397673 | Prevention of pertussis: from clinical trials to Real World Evidence. | J Prev Med Hyg | 2018 | https://conductscience.org/library/papers/30397673 | PubMed |
| 29856680 | Prevention of pertussis: An unresolved problem. | Hum Vaccin Immunother | 2018 | https://conductscience.org/library/papers/29856680 | PubMed |
| 25483496 | Licensed pertussis vaccines in the United States. History and current state. | Hum Vaccin Immunother | 2014 | https://conductscience.org/library/papers/25483496 | PubMed |
| 24918359 | Designing vaccines to neutralize effective toxin delivery by enterotoxigenic Escherichia coli. | Toxins (Basel) | 2014 | https://conductscience.org/library/papers/24918359 | PubMed |
| 22875600 | Cooperative role of antibodies against heat-labile toxin and the EtpA Adhesin in preventing toxin delivery and intestinal colonization by enterotoxigenic Escherichia coli. | Clin Vaccine Immunol | 2012 | https://conductscience.org/library/papers/22875600 | PubMed |
| 22514464 | Acellular pertussis vaccines have arrived. | Can J Infect Dis | 1996 | https://conductscience.org/library/papers/22514464 | PubMed |
| 20107007 | Dose response of attenuated Bordetella pertussis BPZE1-induced protection in mice. | Clin Vaccine Immunol | 2010 | https://conductscience.org/library/papers/20107007 | PubMed |
| 11994035 | Which strategy for pertussis vaccination today? | Paediatr Drugs | 2002 | https://conductscience.org/library/papers/11994035 | PubMed |
| 11401994 | Long-term pertussis-specific immunity after primary vaccination with a combined diphtheria, tetanus, tricomponent acellular pertussis, and hepatitis B vaccine in comparison with that after natural infection. | Infect Immun | 2001 | https://conductscience.org/library/papers/11401994 | PubMed |
| 9673264 | Cytokine mRNA expression and proliferative responses induced by pertussis toxin, filamentous hemagglutinin, and pertactin of Bordetella pertussis in the peripheral blood mononuclear cells of infected and immunized schoolchildren and adults. | Infect Immun | 1998 | https://conductscience.org/library/papers/9673264 | PubMed |
| 9257078 | An overview of the status of acellular pertussis vaccines in practice. | Drugs | 1997 | https://conductscience.org/library/papers/9257078 | PubMed |
| 8926072 | Pertussis-specific cell-mediated immunity in infants after vaccination with a tricomponent acellular pertussis vaccine. | Infect Immun | 1996 | https://conductscience.org/library/papers/8926072 | PubMed |
| 8841742 | A cellular pertussis vaccine (Infanrix-DTPa; SB-3). A review of its immunogenicity, protective efficacy and tolerability in the prevention of Bordetella pertussis infection. | Drugs | 1996 | https://conductscience.org/library/papers/8841742 | PubMed |
| 8664630 | Clinical immunology. | BMJ | 1996 | https://conductscience.org/library/papers/8664630 | PubMed |
Data dates
The date of each source this release read.
- Trials
- 2026-11-12
- Gene search
- 2026-11-11
- Pipelines
- 2026-09-18
None in this release
- Grants
- Trials
- References
- Genes
- Drugs
- Data
Sources 11
- ChEMBL, through Open TargetsCC BY-SA 3.0
- ClinicalTrials.govNo license stated
- HGNCCC0
- iCiteCC BY 4.0
- NCBI GenePublic domain (US government)
- NIH RePORTER's grant and paper linksPublic domain
- Open TargetsCC0 1.0
- PMC's ID filePublic domain (US government)
- PubMedNLM's terms
- PubTator 3Public domain
- UniProtCC BY 4.0
Each source's terms
- ChEMBL, through Open TargetsCC BY-SA 3.0, for the parts from ChEMBL. Read on 8 Nov 2026 at https://platform-docs.opentargets.org/licence
- ClinicalTrials.govnone stated
- HGNCCC0: https://www.genenames.org/about/license/
- iCiteCC BY 4.0
- NCBI GeneNone named for the file. NCBI says information created by or for the US government on its site is in the public domain, and asks that NLM be acknowledged: https://www.ncbi.nlm.nih.gov/home/about/policies/
- NIH RePORTER's grant and paper linksPublic domain (NIH RePORTER)
- Open TargetsCC0 1.0. Open Targets asks that users cite its latest paper: Buniello et al. 2025, Open Targets Platform: facilitating therapeutic hypotheses building in drug discovery, Nucleic Acids Research 53(D1):D1467, PMID 39657122. Read on 8 Nov 2026 at https://platform-docs.opentargets.org/licence
- PMC's ID fileNone named for the file. NCBI says information created by or for the US government on its site is in the public domain, and asks that NLM be acknowledged: https://www.ncbi.nlm.nih.gov/home/about/policies/
- PubMedNLM's terms
- PubTator 3Public domain
- UniProtCC BY 4.0. UniProt's licence file: "All databases and documents in the UniProt FTP directory may be copied and redistributed freely, without advance permission, provided that this copyright statement is reproduced with each copy." UniProt asks that users cite its latest paper: The UniProt Consortium, UniProt: the Universal Protein Knowledgebase in 2025, Nucleic Acids Research 53:D609-D617, https://doi.org/10.1093/nar/gkae1010. Read on 9 Nov 2026 at https://www.uniprot.org/help/license
ClinicalTrials.gov's data carry an international copyright outside the United States: https://clinicaltrials.gov/about-site/terms-conditions.
For software
Read this paper from software.
The record and each of its lists are JSON, twenty rows a page. No key.
GET https://conductscience.org/api/papers/v1/8538712
GET https://conductscience.org/api/papers/v1/8538712/authors